from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3251c/rubA

LFCtreatmentdescriptionclass of inhibitor

1.071

Amikacinug/mL Amikacintranslation

0.037

Cap5-10ug/mL Capreomycintranslation

1.449

Rox10-50 ug/mL Roxithromycintranslation

1.351

SM2-5 ug/mL Streptomycintranslation

2.624

Tet5-10 ug/mL Tetracyclinetranslation

0.063

Rif0.2-5ug/mL Rifampicintranscription

0.305

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.102

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.165

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.526

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.902

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.112

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.337

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.499

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.170

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.766

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.211

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.609

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.426

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.641

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.908

KCN5-20 ug/mL Potassium cyaniderespiration

0.183

NaN30.2-2 mM Sodium aziderespiration

-0.669

Nigericin50 uM Nigericinrespiration

0.661

TRC10-150 ug/mL Triclosanrespiration

-0.764

TRZ10-25 ug/mL Thioridazinerespiration

1.295

Valinomycin0.5-10 uM Valinomycinrespiration

0.934

ZnSO42 mM ZnSO4respiration

-0.305

menadione6-10 ug/mL Menadionerespiration

1.380

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.001

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.390

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.272

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.115

NRP_1Non-replicating persistence stage 1dosRassociated

-0.503

Amp0.2mg/mL AmpicillincellWall

-0.502

Cephalexin20-100 ug/mL CephalexincellWall

-0.063

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.769

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.256

EMB10-20 ug/mL EthambutolcellWall

-0.113

Eta12-40 ug/mL EthionamidecellWall

-0.390

INH0.2-0.4 ug/mL IsoniazidcellWall

0.228

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.574

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.711

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.389

BZA0.12 mg/mL BenzamidearomaticAmides

0.519

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.151

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.170

H2O24 mM hydrogen peroxideDNAdamaging

-0.156

Levo10 ug/mL LevofloxacinDNAdamaging

-0.321

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.513

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.206

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.723

UVUV-irradiationDNAdamaging

-0.748

ARP41-4 ug/mL Antitubercular compound ARP4?

0.063

Antimycin12.5-50 ug/mL Antimycin A?

-0.331

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.054

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.770

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.315

PA8240.2-2 ug/mL PA-824?

-0.968

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.220

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.800

Verapamil50 uM Verapamil?

0.245

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.333

methoxatin10-20 ug/mL Methoxatin?